Randall B. Brenner insider trades: Paratek Pharmaceuticals (PRTK) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Randall reports to the SEC
Open-market buys and sales
14 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 9, 2023 | PRTK | ↓ Sell10b5-1 | 27,603 | $2.20 | $61K | Direct | Aug 10, 2023 (1d) |
| Dec 21, 2022 | PRTK | ↓ Sell10b5-1 | 4,539 | $1.99 | $9K | Direct | Dec 22, 2022 (1d) |
| Dec 13, 2022 | PRTK | ↓ Sell10b5-1 | 29,282 | $1.97 | $58K | Direct | Dec 14, 2022 (1d) |
| Oct 28, 2022 | PRTK | ↓ Sell10b5-1 | 3,516 | $3.47 | $12K | Direct | Nov 1, 2022 (4d) |
| Aug 9, 2022 | PRTK | ↓ Sell10b5-1 | 19,608 | $2.66 | $52K | Direct | Aug 10, 2022 (1d) |
| Dec 15, 2021 | PRTK | ↓ Sell10b5-1 | 27,894 | $4.32 | $121K | Direct | Dec 15, 2021 (0d) |
| Aug 17, 2021 | PRTK | ↓ Sell10b5-1 | 8,766 | $5.12 | $45K | Direct | Aug 18, 2021 (1d) |
| Jun 4, 2021 | PRTK | ↓ Sell10b5-1 | 9,978 | $9.70 | $97K | Direct | Jun 8, 2021 (4d) |
| Dec 14, 2020 | PRTK | ↓ Sell10b5-1 | 14,924 | $6.81 | $102K | Direct | Dec 15, 2020 (1d) |
| Nov 13, 2020 | PRTK | ↓ Sell10b5-1 | 8,357 | $5.93 | $50K | Direct | Nov 16, 2020 (3d) |
| May 12, 2020 | PRTK | ↓ Sell | 6,198 | $4.75 | $29K | Direct | May 14, 2020 (2d) |
| Dec 12, 2019 | PRTK | ↓ Sell | 6,278 | $3.10 | $19K | Direct | Dec 16, 2019 (4d) |
| Oct 8, 2019 | PRTK | ↓ Sell10b5-1 | 5,049 | $3.82 | $19K | Direct | Oct 8, 2019 (0d) |
| Oct 3, 2019 | PRTK | ↓ Sell | 7,674 | $3.98 | $31K | Direct | Oct 7, 2019 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Randall B. Brenner's insider trades
Randall B. Brenner is Chief Development & Regulatory at Paratek Pharmaceuticals (PRTK). Since Oct 3, 2019, Randall has reported no open-market purchases and 14 sales worth $704K on SEC Form 4. There have been no open-market trades in the last 12 months.
11 sales (89% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (11 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PRTK insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.